Recurrent disease after negative second-look laparotomy in stages III and IV ovarian carcinoma.
Between 1977 and 1984, second-look laparotomy to evaluate disease status after adjuvant chemotherapy was performed in 134 patients originally presenting with advanced epithelial ovarian carcinoma. Surgical and histologic assessment did not detect persistent disease in 50 patients (37%). Recurrent carcinoma was subsequently documented in 15 patients (30%), all failures occurring within the abdominal cavity or the retroperitoneal space. Several patient subgroups at high risk for recurrence after negative second-look laparotomy are identified that might benefit from additional adjunctive therapy. Because of different treatment-associated morbidities, the corresponding sensitivities and specificities of the high-risk groups may assist subsequent treatment selection.
Podratz
K C
KC
Department of Obstetrics and Gynecology, Mayo Clinic, Rochester, Minnesota 55905.
Malkasian
G D
GD
Wieand
H S
HS
Cha
S S
SS
Lee
R A
RA
Stanhope
C R
CR
Williams
T J
TJ
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002277:Carcinoma / Q000188:drug therapy / Q000473:pathology* / Q000556:secondary; D005260:Female; D006801:Humans; D007813:Laparotomy; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D010051:Ovarian Neoplasms / Q000188:drug therapy / Q000473:pathology*; D010386:Pelvic Neoplasms / Q000556:secondary; D011379:Prognosis; D012086:Reoperation